BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
10.75
-0.13 (-1.19%)
At close: May 30, 2025, 4:00 PM
10.89
+0.14 (1.30%)
After-hours: May 30, 2025, 7:25 PM EDT

BioCryst Pharmaceuticals Market Cap

BioCryst Pharmaceuticals has a market cap or net worth of $2.25 billion as of May 30, 2025. Its market cap has increased by 103.35% in one year.

Market Cap
2.25B
Enterprise Value
2.78B
1-Year Change
103.35%
Ranking
Category
Stock Price
$10.75

Market Cap Chart

Since December 1, 1998, BioCryst Pharmaceuticals's market cap has increased from $100.40M to $2.25B, an increase of 2,140.48%. That is a compound annual growth rate of 12.44%.

History

DateMarket Cap% Change
May 30, 20252.25B44.41%
Dec 31, 20241.56B26.96%
Dec 29, 20231.23B-42.68%
Dec 30, 20222.14B-14.12%
Dec 31, 20212.49B89.46%
Dec 31, 20201.32B245.25%
Dec 31, 2019381.00M-56.94%
Dec 31, 2018884.80M83.11%
Dec 29, 2017483.20M3.49%
Dec 30, 2016466.90M-38.31%
Dec 31, 2015756.80M-13.40%
Dec 31, 2014873.90M94.59%
Dec 31, 2013449.10M522.02%
Dec 31, 201272.20M-35.36%
Dec 30, 2011111.70M-51.92%
Dec 31, 2010232.30M-7.38%
Dec 31, 2009250.80M378.63%
Dec 31, 200852.40M-77.65%
Dec 31, 2007234.50M-30.60%
Dec 29, 2006337.90M-23.72%
Dec 30, 2005443.00M252.71%
Dec 31, 2004125.60M3.37%
Dec 31, 2003121.50M614.71%
Dec 31, 200217.00M-75.61%
Dec 31, 200169.70M-40.02%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 662.23B
Johnson & Johnson 373.45B
AbbVie 328.75B
Novo Nordisk 305.07B
UnitedHealth Group 273.87B
Abbott Laboratories 232.41B
AstraZeneca 224.00B
Novartis AG 223.92B
Market Cap Rankings